MedPath

Deep Brain Stimulation in Chronic Treatment refractory Drug Dependence: A Pilot Study

Conditions
treatment resistant drug dependence
untreatable addiction
10021563
Registration Number
NL-OMON35020
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
8
Inclusion Criteria

- Chronic course of substance use disorder: minimal duration of 5 years of DSM-IV diagnosis heroin and/or cocaine dependence
- Being treatment refractory despite treatment programs
- Severe dependence: heroin/cocaine use at least 15 days in last month AND poor physical health AND/OR poor mental health AND/OR poor social functioning

Exclusion Criteria

- Current major depression, current suicidality, current OCD.
- Current psychosis and no history of psychosis
- (history of) severe neurological disorders
- Contraindication to perform the operation
- Contraindication to participate in fMRI and/or SPECT assesment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome measurements include subjective craving and illicit drug use.<br /><br>In addition, urinalysis will be performed to validate self-reported drug use.<br /><br>Concerning the imaging experiments the outcome will be assessed by changes in<br /><br>brain activity with fMRI and changes in striatal dopamine D2 binding with<br /><br>SPECT. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes include social function and quality of life.</p><br>
© Copyright 2025. All Rights Reserved by MedPath